Joel Greenblatt's BSX Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 159,168 shares of Boston Scientific Corporation (BSX) worth $15.18 M, representing 0.06% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 36 quarters.
Based on 13F filings, Joel Greenblatt has maintained a strategic position in BSX, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2017, adding 1.56 M shares. Largest reduction occurred in Q2 2017, reducing 1.64 M shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Boston Scientific Corporation (BSX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Boston Scientific Corporation (BSX) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -41,944 | Reduce 20.86% | 159,168 | $95.35 |
| Q3 2025 | +126,595 | Add 169.89% | 201,112 | $97.63 |
| Q2 2025 | +39,545 | Add 113.08% | 74,517 | $107.41 |
| Q1 2025 | +23,542 | Add 205.97% | 34,972 | $100.88 |
| Q4 2024 | +3,475 | Add 43.68% | 11,430 | $89.32 |
| Q3 2024 | +1,840 | Add 30.09% | 7,955 | $83.80 |
| Q2 2024 | -231 | Reduce 3.64% | 6,115 | $77.01 |
| Q1 2024 | +1,338 | Add 26.72% | 6,346 | $68.49 |
| Q4 2023 | +849 | Add 20.41% | 5,008 | $57.81 |
| Q3 2023 | -20,535 | Reduce 83.16% | 4,159 | $52.80 |
| Q2 2023 | +20,650 | Add 510.63% | 24,694 | $54.09 |
| Q1 2023 | +4,044 | New Buy | 4,044 | $50.03 |
| Q2 2022 | -8,693 | Sold Out | 0 | $0.00 |
| Q1 2022 | +2,108 | Add 32.01% | 8,693 | $44.29 |
| Q4 2021 | -100,854 | Reduce 93.87% | 6,585 | $42.52 |
| Q3 2021 | +95,930 | Add 833.52% | 107,439 | $43.39 |
| Q2 2021 | -2,156 | Reduce 15.78% | 11,509 | $42.75 |
| Q1 2021 | +6,116 | Add 81.02% | 13,665 | $38.64 |
| Q4 2020 | -2,161 | Reduce 22.26% | 7,549 | $35.90 |
| Q3 2020 | -12,215 | Reduce 55.71% | 9,710 | $38.21 |
| Q2 2020 | -1,543 | Reduce 6.57% | 21,925 | $35.12 |
| Q1 2020 | +23,468 | New Buy | 23,468 | $32.64 |
| Q2 2019 | -19,943 | Sold Out | 0 | $0.00 |
| Q1 2019 | +10,099 | Add 102.59% | 19,943 | $38.36 |
| Q4 2018 | -71 | Reduce 0.72% | 9,844 | $35.35 |
| Q3 2018 | -49,745 | Reduce 83.38% | 9,915 | $38.53 |
| Q2 2018 | +59,660 | New Buy | 59,660 | $32.70 |
| Q1 2018 | -503,669 | Sold Out | 0 | $0.00 |
| Q4 2017 | +475,026 | Add 1658.44% | 503,669 | $24.79 |
| Q3 2017 | +4,046 | Add 16.45% | 28,643 | $29.19 |
| Q2 2017 | -1.64 M | Reduce 98.52% | 24,597 | $27.73 |
| Q1 2017 | +1.56 M | Add 1574.40% | 1.66 M | $24.87 |
| Q4 2016 | +99,384 | New Buy | 99,384 | $21.63 |
| Q4 2013 | -18,744 | Sold Out | 0 | $0.00 |
| Q3 2013 | -42,150 | Reduce 69.22% | 18,744 | $11.74 |
| Q2 2013 | +60,894 | Add 0.00% | 60,894 | $9.26 |
Joel Greenblatt's Boston Scientific Corporation Investment FAQs
Joel Greenblatt first purchased Boston Scientific Corporation (BSX) in Q2 2013, acquiring 60,894 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Boston Scientific Corporation (BSX) for 36 quarters since Q2 2013.
Joel Greenblatt's largest addition to Boston Scientific Corporation (BSX) was in Q1 2017, adding 1,664,082 shares worth $41.39 M.
According to the latest 13F filing for Q4 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 159,168 shares of Boston Scientific Corporation (BSX), valued at approximately $15.18 M.
As of the Q4 2025 filing, Boston Scientific Corporation (BSX) represents approximately 0.06% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Boston Scientific Corporation (BSX) was 1,664,082 shares, as reported at the end of Q1 2017.